Oral appliances reduce masticatory muscle activity-sleep bruxism metrics independently of changes in heart rate variability
ConclusionsThe usage of OAs for SB participants reduced RMMA, but most likely independently of changes in HRV linked to the mechanism associated with SB genesis.Clinical relevanceWearing OA seems to reduce grinding noise and protect from dental injuries but does not seem to influence SB genesis. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 20, 2022 Category: Dentistry Source Type: news

How Do I Get Rid of My Baby's Moro Reflex?
Title: How Do I Get Rid of My Baby ' s Moro Reflex?Category: Diseases and ConditionsCreated: 1/15/2021 12:00:00 AMLast Editorial Review: 5/18/2022 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - May 18, 2022 Category: Pediatrics Source Type: news

Recovery mechanisms in the dragonfly righting reflex
Science,<a href="https://www.science.org/toc/science/376/6594">Volume 376, Issue 6594</a>, Page 754-758, May 2022. (Source: ScienceNOW)
Source: ScienceNOW - May 12, 2022 Category: Science Authors: Z. Jane Wang, James Melfi, Anthony Leonardo Source Type: news

Five New Neurology Studies: Possible Breakthroughs, Some Failures Five New Neurology Studies: Possible Breakthroughs, Some Failures
Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 9, 2022 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Muscular dystrophy startup goes public in $108M IPO
PepGen, a Boston-based startup developing medicine for muscular dystrophies, raised $108 million in its Wall Street debut. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 6, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

New three-year data for Roche ’s Evrysdi (risdiplam) show long-term improvements in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
91% of infants treated withEvrysdi in the FIREFISH study were still alive at three yearsInfants treated withEvrysdi maintained or continued to improve in measures of motor function, including their ability to sit without support for 5 and 30 secondsEvrysdi has proven efficacy in infants and adults, with over 5,000 patients treated to dateBasel, 29 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new three-year data from the FIREFISH study, including one-year data from the open label extension, reinforcing the long-term efficacy and safety of Evrysdi ® (risdiplam) in infants with symptomatic Type 1 spinal mu...
Source: Roche Media News - April 29, 2022 Category: Pharmaceuticals Source Type: news

New three-year data for Roche ’s Evrysdi (risdiplam) show long-term improvements in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
91% of infants treated withEvrysdi in the FIREFISH study were still alive at three yearsInfants treated withEvrysdi maintained or continued to improve in measures of motor function, including their ability to sit without support for 5 and 30 secondsEvrysdi has proven efficacy in infants and adults, with over 5,000 patients treated to dateBasel, 29 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new three-year data from the FIREFISH study, including one-year data from the open label extension, reinforcing the long-term efficacy and safety of Evrysdi ® (risdiplam) in infants with symptomatic Type 1 spinal mu...
Source: Roche Investor Update - April 29, 2022 Category: Pharmaceuticals Source Type: news

Trial May Set Standard for Steroid Therapy in Duchenne Muscular Dystrophy
(MedPage Today) -- SEATTLE -- Prednisone or deflazacort given every day were superior to prednisone on a 1o-days-on, 10-days-off schedule for boys with Duchenne muscular dystrophy (DMD), a researcher reported. In the international randomized... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 27, 2022 Category: Endocrinology Source Type: news

Supreme Court seems sympathetic to a coach who claims the right to pray
#supremecourt (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2022 Category: Consumer Health News Source Type: news

U.S. Supreme Court conservatives lean toward football coach in prayer case
The U.S. Supreme Court's conservative majority on Monday appeared sympathetic toward an appeal by a Christian former public high school football coach in Washington state who was suspended from... #ussupremecourt #washingtonstate #footballcoach #conservatives #highschoolfootballcoach (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2022 Category: Consumer Health News Source Type: news

Health delegates lay blame for NHS problems squarely on Tories
The responsibility for the struggle facing the NHS was at the heart of the message in the first motion, when UNISON’s first in-person health conference since 2019 opened in Liverpool this morning. And the gist of it was: “The blame lies with this government – not COVID.” In the first of a series of motions on health, safety and wellbeing, Eddie Woolley for the service group executive told delegates that, in the 10 years leading up to the pandemic, “we have been shouting from the rooftops about the lack of investment … the government have done nothing.” The health service now faced a situation where ...
Source: UNISON Health care news - April 25, 2022 Category: UK Health Authors: Amanda Kendal Tags: Article News 2022 Health Care Service Group Conference NHS Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Basel, 25 April 2022Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early...
Source: Roche Media News - April 25, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early-stage non-small cel...
Source: Roche Investor Update - April 25, 2022 Category: Pharmaceuticals Source Type: news

Reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern, UKHSA (updated 20th April 2022)
Information on the use of reflex (genotyping) assays for identification of priority SARS-CoV-2 variants of concern. 20 April 2022Updated guidance. 15 July 2021First published. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 20, 2022 Category: Consumer Health News Source Type: news

Gilbert Gottfried's Myotonic Dystrophy
(MedPage Today) -- Gilbert Gottfried, a stand-up comedian who liked to push the envelope when it came to political correctness, passed away this week at the age of 67. Best known for his distinctive voice, both as the Aflac duck and as the wisecracking... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 15, 2022 Category: Cardiology Source Type: news